Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal

Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal

Introduction: Information about pan-genotypic treatments for hepatitis in Portugal is scarce. We aimed to evaluate the effectiveness and safety of glecaprevir plus pibrentasvir (GLE/PIB) treatment for hepatitis C virus (HCV) infection in real-world clinical practice. Methods: An observational prosp...

Full description

Bibliographic Details
Main Authors: José Vera, André Gomes, Diana Póvoas, Diana Seixas, Fernando Maltez, Isabel Pedroto, Luís Maia, Margarida Mota, Maria João Vieira, Maria José Manata, Paula Ferreira, Sara Lino, Tiago Pereira Guedes, Vânia Barradas, Nuno Marques
Format: Article
Language:English
Published: Ordem dos Médicos 2024-02-01
Series:Acta Médica Portuguesa
Subjects:
Genotype
Glecaprevir
Hepatitis C, Chronic/drug therapy
Pibrentasvir
Portugal
Treatment Outcome
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19178

Internet

https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19178

Similar Items